Your Location：
Home >
Browse articles >
Aspartoacylase suppresses prostate cancer progres-sion by blocking LYN activation
RESEARCH | Updated：2025-12-13

    • Aspartoacylase suppresses prostate cancer progres-sion by blocking LYN activation

    • “Reporting on a breakthrough in prostate cancer research, a study at Zhongnan Hospital of Wuhan University identifies aspartoacylase (ASPA) as a novel inhibitor of disease progression. The research, which involved advanced transcriptomic methodologies and comprehensive in vitro and in vivo assays, found that ASPA's decreased expression is associated with poor patient prognosis and that its activity suppresses cancer cell proliferation and metastasis. The study reveals ASPA's direct interaction with LYN, inhibiting its phosphorylation and downstream signaling, offering a new direction for prostate cancer management.”
    • Military Medical Research   Vol. 11, Issue 2, Pages: 180-205(2024)

    • DOI：10.1186/s40779-023-00460-0    

      CLC：

    • Published：2024-04

    Scan QR Code

  • Cite this article as: Weng H, Xiong KP, Wang W, Qian KY, Yuan S, Wang G, et al. Aspartoacylase suppresses prostate cancer progression by blocking LYN activation. Mil Med Res. 2023;10(1):25. DOI： 10.1186/s40779-023-00460-0.

  •  
  •  

0

Views

3

Downloads

0

CSCD

Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album

Related Articles

Performance of GPT-4 for automated prostate biopsy decision-making based on mpMRI: a multi-center evidence study
Global burden of benign prostatic hyperplasia, urinary tract infections, urolithiasis, bladder cancer, kidney cancer, and prostate cancer from 1990 to 2021
ADP-dependent glucokinase: the ancient, archaeal key to prostate cancer
The implications of single-cell RNA-seq analysis in prostate cancer: unraveling tumor heterogeneity, therapeutic implications and pathways towards personalized therapy
Kalman Dynamic Adaptive Filtering to Railway Line Measurement Signals of Tilting Train

Related Author

Zhen-Chang Wang
Ming-Jun Shi
Zhi-Xiang Wang
Shuang-Kun Wang
Xuan-Hao Li
Yan-Lin Zhang
Ying Yan
Ran An

Related Institution

Division of Science and Technology, Beijing Friendship Hospital, Capital Medical University
Department of Urology, Beijing Friendship Hospital, Capital Medical University
Institute of Urology, Beijing Municipal Health Commission
Department of Radiology, Beijing Friendship Hospital, Capital Medical University
Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University
0